|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00252525 |
|
Date of registration:
|
09/11/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2
|
|
Scientific title:
|
CSP #465B - Correlation of Plasma Endothelial Cell (Basic Fibroblast Growth Factor) Activity With Cardiovascular Events In Patients With Diabetes Mellitus Type 2 |
|
Date of first enrolment:
|
June 2007 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00252525 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Carlos Abraira, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Miami VA Healthcare System, Miami, FL |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Patients with type 2 DM who are no longer responsive to maximum dose of one or more oral
agents.
Exclusion Criteria:
Not a part of the VADT.
Age minimum:
40 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Type 2 Diabetes Mellitus
|
|
Primary Outcome(s)
|
|
The primary outcome measures are cardiovascular morbidity and mortality.
[Time Frame: End of study.]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|